Patient-derived xenografts from colorectal carcinoma

A temporal and hierarchical study of murine stromal cell replacement

Celia Chao, Steven Widen, Thomas Wood, John R. Zatarain, Paul Johnson, Aakash Gajjar, Guillermo Gomez, Suimin Qiu, Jill Thompson, Heidi Spratt, Mark Hellmich

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background/Aim: Patient-derived xenografting (PDX) of human colorectal cancer (CRC) is the preferred experimental model to study tumor response to therapeutic agentS. Gradually, human stromal cells are replaced by mouse stromal cells; however, the exact timing of the replacement of human with murine stromal cells in human CRC xenograft has not been fully elucidated. We hypothesize that orthologous murine transcripts functionally substitutes for the loss due to replacement of human stromal geneS. Materials and Methods: Human CRC were implanted in athymic nude mice in replicates and followed-up over time. Using next-generation sequencing, we determined the temporal kinetics of human stromal cell replacement with the orthologous murine transcriptS. Results: CRC cell-induced re-organization of the normal, quiescent murine stromal cells into a protumorigenic phenotype supporting human CRC growth occurs at initial implantation. Conclusion: Murine cell replacement occurs in a time-and size-dependent manner.

Original languageEnglish (US)
Pages (from-to)3405-3412
Number of pages8
JournalAnticancer Research
Volume37
Issue number7
DOIs
StatePublished - Jul 1 2017

Fingerprint

Stromal Cells
Heterografts
Colorectal Neoplasms
Nude Mice
Heterologous Transplantation
Theoretical Models
Phenotype
Growth
Genes
Neoplasms

Keywords

  • Human colorectal carcinoma
  • Next-generation sequencing
  • Patient derived xenografts

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Patient-derived xenografts from colorectal carcinoma : A temporal and hierarchical study of murine stromal cell replacement. / Chao, Celia; Widen, Steven; Wood, Thomas; Zatarain, John R.; Johnson, Paul; Gajjar, Aakash; Gomez, Guillermo; Qiu, Suimin; Thompson, Jill; Spratt, Heidi; Hellmich, Mark.

In: Anticancer Research, Vol. 37, No. 7, 01.07.2017, p. 3405-3412.

Research output: Contribution to journalArticle

Chao, Celia ; Widen, Steven ; Wood, Thomas ; Zatarain, John R. ; Johnson, Paul ; Gajjar, Aakash ; Gomez, Guillermo ; Qiu, Suimin ; Thompson, Jill ; Spratt, Heidi ; Hellmich, Mark. / Patient-derived xenografts from colorectal carcinoma : A temporal and hierarchical study of murine stromal cell replacement. In: Anticancer Research. 2017 ; Vol. 37, No. 7. pp. 3405-3412.
@article{d693242ef73b44b4acf68073df6fa058,
title = "Patient-derived xenografts from colorectal carcinoma: A temporal and hierarchical study of murine stromal cell replacement",
abstract = "Background/Aim: Patient-derived xenografting (PDX) of human colorectal cancer (CRC) is the preferred experimental model to study tumor response to therapeutic agentS. Gradually, human stromal cells are replaced by mouse stromal cells; however, the exact timing of the replacement of human with murine stromal cells in human CRC xenograft has not been fully elucidated. We hypothesize that orthologous murine transcripts functionally substitutes for the loss due to replacement of human stromal geneS. Materials and Methods: Human CRC were implanted in athymic nude mice in replicates and followed-up over time. Using next-generation sequencing, we determined the temporal kinetics of human stromal cell replacement with the orthologous murine transcriptS. Results: CRC cell-induced re-organization of the normal, quiescent murine stromal cells into a protumorigenic phenotype supporting human CRC growth occurs at initial implantation. Conclusion: Murine cell replacement occurs in a time-and size-dependent manner.",
keywords = "Human colorectal carcinoma, Next-generation sequencing, Patient derived xenografts",
author = "Celia Chao and Steven Widen and Thomas Wood and Zatarain, {John R.} and Paul Johnson and Aakash Gajjar and Guillermo Gomez and Suimin Qiu and Jill Thompson and Heidi Spratt and Mark Hellmich",
year = "2017",
month = "7",
day = "1",
doi = "10.21873/anticanreS.11707",
language = "English (US)",
volume = "37",
pages = "3405--3412",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "7",

}

TY - JOUR

T1 - Patient-derived xenografts from colorectal carcinoma

T2 - A temporal and hierarchical study of murine stromal cell replacement

AU - Chao, Celia

AU - Widen, Steven

AU - Wood, Thomas

AU - Zatarain, John R.

AU - Johnson, Paul

AU - Gajjar, Aakash

AU - Gomez, Guillermo

AU - Qiu, Suimin

AU - Thompson, Jill

AU - Spratt, Heidi

AU - Hellmich, Mark

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Background/Aim: Patient-derived xenografting (PDX) of human colorectal cancer (CRC) is the preferred experimental model to study tumor response to therapeutic agentS. Gradually, human stromal cells are replaced by mouse stromal cells; however, the exact timing of the replacement of human with murine stromal cells in human CRC xenograft has not been fully elucidated. We hypothesize that orthologous murine transcripts functionally substitutes for the loss due to replacement of human stromal geneS. Materials and Methods: Human CRC were implanted in athymic nude mice in replicates and followed-up over time. Using next-generation sequencing, we determined the temporal kinetics of human stromal cell replacement with the orthologous murine transcriptS. Results: CRC cell-induced re-organization of the normal, quiescent murine stromal cells into a protumorigenic phenotype supporting human CRC growth occurs at initial implantation. Conclusion: Murine cell replacement occurs in a time-and size-dependent manner.

AB - Background/Aim: Patient-derived xenografting (PDX) of human colorectal cancer (CRC) is the preferred experimental model to study tumor response to therapeutic agentS. Gradually, human stromal cells are replaced by mouse stromal cells; however, the exact timing of the replacement of human with murine stromal cells in human CRC xenograft has not been fully elucidated. We hypothesize that orthologous murine transcripts functionally substitutes for the loss due to replacement of human stromal geneS. Materials and Methods: Human CRC were implanted in athymic nude mice in replicates and followed-up over time. Using next-generation sequencing, we determined the temporal kinetics of human stromal cell replacement with the orthologous murine transcriptS. Results: CRC cell-induced re-organization of the normal, quiescent murine stromal cells into a protumorigenic phenotype supporting human CRC growth occurs at initial implantation. Conclusion: Murine cell replacement occurs in a time-and size-dependent manner.

KW - Human colorectal carcinoma

KW - Next-generation sequencing

KW - Patient derived xenografts

UR - http://www.scopus.com/inward/record.url?scp=85021743182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021743182&partnerID=8YFLogxK

U2 - 10.21873/anticanreS.11707

DO - 10.21873/anticanreS.11707

M3 - Article

VL - 37

SP - 3405

EP - 3412

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 7

ER -